Drug­mak­ers 'inch­ing ahead' in in­creas­ing ac­cess to drugs world­wide, with Glax­o­SmithK­line lead­ing the pack

Top drug de­vel­op­ers are “inch­ing ahead” in im­prov­ing ac­cess to much-need­ed drugs around the world — an is­sue that has been un­der­scored by the Covid-19 pan­dem­ic. But there’s still more work to do, Ac­cess to Med­i­cine Foun­da­tion ex­ec­u­tive di­rec­tor Jayas­ree Iy­er said.

Every two years, the Ac­cess to Med­i­cines In­dex ranks the top 20 biotechs lead­ing the push for bet­ter ac­cess to med­i­cines in low- and mid­dle-in­come coun­tries. This year’s re­port, pub­lished Tues­day, looks at drug ac­cess in 106 coun­tries.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER